Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV Real-World Multi-Country Observational Study on Patients' Disease Control and Self-Reported Outcomes During Fixed Dose Combination Inhaler Treatment for Persistent Asthma and COPD

NCT02419872 is registered in ClinicalTrials.gov with Teva Pharmaceuticals Europe as lead sponsor.

NCT NCT02419872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02419872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV Real-World Multi-Country Observational Study on Patients' Disease Control and Self-Reported Outcomes During Fixed Dose Combination Inhaler Treatment for Persistent Asthma and COPD
Lead sponsor
Teva Pharmaceuticals Europe
Phase
Observational
Overall status
Completed
Start date
May 31, 2015
Completion date
April 7, 2017
Enrollment
1,743 (actual)
Sites
141

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, chronic obstructive pulmonary disease